11C-蛋氨酸正电子发射断层扫描的最大标准化摄取值可预测口腔鳞状细胞癌患者的预后。

IF 1.9 3区 医学 Q2 DENTISTRY, ORAL SURGERY & MEDICINE
Odontology Pub Date : 2025-01-01 Epub Date: 2024-05-04 DOI:10.1007/s10266-024-00946-w
Takeshi Kuroshima, Yoshimasa Kitagawa, Jun Sato, Shiro Watanabe, Takuya Asaka, Takahiro Abe, Hiroyuki Harada, Kenji Hirata, Yuji Kuge
{"title":"11C-蛋氨酸正电子发射断层扫描的最大标准化摄取值可预测口腔鳞状细胞癌患者的预后。","authors":"Takeshi Kuroshima, Yoshimasa Kitagawa, Jun Sato, Shiro Watanabe, Takuya Asaka, Takahiro Abe, Hiroyuki Harada, Kenji Hirata, Yuji Kuge","doi":"10.1007/s10266-024-00946-w","DOIUrl":null,"url":null,"abstract":"<p><p>The present study aimed to elucidate the correlation between the uptake of <sup>11</sup>C-methionine (MET) by a primary tumor and the survival of patients with oral squamous cell carcinoma (OSCC). This study enrolled 31 patients who underwent radical surgery for OSCC. The patients underwent pretreatment MET-positron emission tomography (PET) scanning. We analyzed correlations between the maximum standardized uptake value (SUV<sub>max</sub>) of MET-PET in a primary tumor and the clinicopathological features. Further, we compared overall survival (OS), disease-specific survival (DSS), and loco-regional recurrence (LRR) rates between the two groups according to SUV<sub>max</sub> of MET-PET. SUV<sub>max</sub> of MET-PET in a primary tumor was higher in patients with advanced T-classification and advanced clinical stage, with significant differences (P = 0.001 and P = 0.016, respectively). The patients with SUV<sub>max</sub> of MET-PET ≥ 4.4 showed significantly lower DSS rates and higher LRR rates than those with SUV<sub>max</sub> of < 4.4 (P = 0.015 and P = 0.016, respectively). SUV<sub>max</sub> of MET-PET and OS rates showed no significant correlation (P = 0.073). The present study revealed that SUV<sub>max</sub> of MET-PET may predict clinical outcomes and prognosis in patients with OSCC who underwent radical surgery.</p>","PeriodicalId":19390,"journal":{"name":"Odontology","volume":" ","pages":"372-378"},"PeriodicalIF":1.9000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Maximum standardized uptake value in <sup>11</sup>C-methionine positron emission tomography may predict the prognosis of patients with oral squamous cell carcinoma.\",\"authors\":\"Takeshi Kuroshima, Yoshimasa Kitagawa, Jun Sato, Shiro Watanabe, Takuya Asaka, Takahiro Abe, Hiroyuki Harada, Kenji Hirata, Yuji Kuge\",\"doi\":\"10.1007/s10266-024-00946-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The present study aimed to elucidate the correlation between the uptake of <sup>11</sup>C-methionine (MET) by a primary tumor and the survival of patients with oral squamous cell carcinoma (OSCC). This study enrolled 31 patients who underwent radical surgery for OSCC. The patients underwent pretreatment MET-positron emission tomography (PET) scanning. We analyzed correlations between the maximum standardized uptake value (SUV<sub>max</sub>) of MET-PET in a primary tumor and the clinicopathological features. Further, we compared overall survival (OS), disease-specific survival (DSS), and loco-regional recurrence (LRR) rates between the two groups according to SUV<sub>max</sub> of MET-PET. SUV<sub>max</sub> of MET-PET in a primary tumor was higher in patients with advanced T-classification and advanced clinical stage, with significant differences (P = 0.001 and P = 0.016, respectively). The patients with SUV<sub>max</sub> of MET-PET ≥ 4.4 showed significantly lower DSS rates and higher LRR rates than those with SUV<sub>max</sub> of < 4.4 (P = 0.015 and P = 0.016, respectively). SUV<sub>max</sub> of MET-PET and OS rates showed no significant correlation (P = 0.073). The present study revealed that SUV<sub>max</sub> of MET-PET may predict clinical outcomes and prognosis in patients with OSCC who underwent radical surgery.</p>\",\"PeriodicalId\":19390,\"journal\":{\"name\":\"Odontology\",\"volume\":\" \",\"pages\":\"372-378\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Odontology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10266-024-00946-w\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/5/4 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"DENTISTRY, ORAL SURGERY & MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Odontology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10266-024-00946-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/4 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
引用次数: 0

摘要

本研究旨在阐明原发肿瘤摄取11C-蛋氨酸(MET)与口腔鳞状细胞癌(OSCC)患者生存期之间的相关性。这项研究选取了31名接受OSCC根治术的患者。患者接受了治疗前的 MET 正电子发射断层扫描(PET)扫描。我们分析了原发肿瘤中MET-PET最大标准化摄取值(SUVmax)与临床病理特征之间的相关性。此外,我们还根据 MET-PET 的 SUVmax 比较了两组患者的总生存率(OS)、疾病特异性生存率(DSS)和局部区域复发率(LRR)。T分类晚期和临床分期晚期患者原发肿瘤的MET-PET SUVmax更高,差异显著(分别为P = 0.001和P = 0.016)。MET-PET的SUVmax≥4.4的患者的DSS率明显低于MET-PET的SUVmax≥4.4的患者,LRR率明显高于MET-PET的SUVmax≥4.4的患者,OS率与MET-PET的SUVmax≥4.4的患者无明显相关性(P = 0.073)。本研究表明,MET-PET的SUVmax可预测接受根治性手术的OSCC患者的临床结果和预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Maximum standardized uptake value in <sup>11</sup>C-methionine positron emission tomography may predict the prognosis of patients with oral squamous cell carcinoma.

Maximum standardized uptake value in 11C-methionine positron emission tomography may predict the prognosis of patients with oral squamous cell carcinoma.

The present study aimed to elucidate the correlation between the uptake of 11C-methionine (MET) by a primary tumor and the survival of patients with oral squamous cell carcinoma (OSCC). This study enrolled 31 patients who underwent radical surgery for OSCC. The patients underwent pretreatment MET-positron emission tomography (PET) scanning. We analyzed correlations between the maximum standardized uptake value (SUVmax) of MET-PET in a primary tumor and the clinicopathological features. Further, we compared overall survival (OS), disease-specific survival (DSS), and loco-regional recurrence (LRR) rates between the two groups according to SUVmax of MET-PET. SUVmax of MET-PET in a primary tumor was higher in patients with advanced T-classification and advanced clinical stage, with significant differences (P = 0.001 and P = 0.016, respectively). The patients with SUVmax of MET-PET ≥ 4.4 showed significantly lower DSS rates and higher LRR rates than those with SUVmax of < 4.4 (P = 0.015 and P = 0.016, respectively). SUVmax of MET-PET and OS rates showed no significant correlation (P = 0.073). The present study revealed that SUVmax of MET-PET may predict clinical outcomes and prognosis in patients with OSCC who underwent radical surgery.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Odontology
Odontology 医学-牙科与口腔外科
CiteScore
5.30
自引率
4.00%
发文量
91
审稿时长
>12 weeks
期刊介绍: The Journal Odontology covers all disciplines involved in the fields of dentistry and craniofacial research, including molecular studies related to oral health and disease. Peer-reviewed articles cover topics ranging from research on human dental pulp, to comparisons of analgesics in surgery, to analysis of biofilm properties of dental plaque.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信